Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
2 papers
This large review combined 441 randomized trials with 33,881 patients to measure how many people show a clear response to psychotherapy across eight mental disorders. Response was defined as at least a 50% reduction in symptoms from before to after treatment. Pooled response rates were modest (for example, about 42%…
Researchers reviewed published clinical trials testing psychedelic drugs for people diagnosed with anxiety disorders. They found nine trials that used ayahuasca, ketamine, LSD, MDMA, or psilocybin. Overall, the studies showed reduced anxiety symptoms and better self-image or social functioning for people with generalized anxiety, social anxiety, or anxiety linked to…
